Evolus Inc banner

Evolus Inc
NASDAQ:EOLS

Watchlist Manager
Evolus Inc Logo
Evolus Inc
NASDAQ:EOLS
Watchlist
Price: 5.01 USD 2.04% Market Closed
Market Cap: $324.7m

During the last 3 months Evolus Inc insiders have not bought any shares, and sold 91.5k USD worth of shares. The stock price has dropped by 30% over this period (open performance analysis).

The last transaction was made on Dec 22, 2025 by Avelar Rui , who sold 16.2k USD worth of EOLS shares.

Last Transactions:
Moatazedi David
$-75.4k
Avelar Rui
$-16.2k
Yamagishi-Dressler Tomoko
$-43k
Stewart Brady
$+204.5k
Moatazedi David
$-164.1k
Moatazedi David
$-1.1m
White Albert G Iii
$+189k
Beaver Sandra
$-65.1k
Moatazedi David
$-155.8k
Avelar Rui
$-33.4k
Moatazedi David
$-77.5k
Beaver Sandra
$-119.2k
Yamagishi-Dressler Tomoko
$-60.1k
Moatazedi David
$-1.4m
Avelar Rui
$-369.9k
Parschauer Karah Herdman
$-167.5k
Moatazedi David
$-114k
Avelar Rui
$-24.4k
Beaver Sandra
$-17.2k
Beaver Sandra
$-49.1k
Yamagishi-Dressler Tomoko
$-89.3k
Moatazedi David
$-2.2m
Moatazedi David
$-2m
Moatazedi David
$-1.8m
Malik Vikram
$-97.2k
Gill David N
$-84.7k
Gill David N
$-46.4k
Malik Vikram
$-362k
Moatazedi David
$-204.1k
Avelar Rui
$-43.8k
Beaver Sandra
$-30.8k
Moatazedi David
$-86.4k
View All Transactions

During the last 3 months Evolus Inc insiders have not bought any shares, and sold 91.5k USD worth of shares. The stock price has dropped by 30% over this period (open performance analysis).

The last transaction was made on Dec 22, 2025 by Avelar Rui , who sold 16.2k USD worth of EOLS shares.

Sold
0-3
months
91.5k USD
2
3-6
months
0 USD
0
6-9
months
207k USD
2
9-12
months
3.4m USD
4
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
1
204.5k USD
9-12
months
1
189k USD

Evolus Inc
Insider Trading Chart

Evolus Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Evolus Inc
Last Insider Transactions

Global
Insiders Monitor

Evolus Inc
Glance View

Market Cap
324.7m USD
Industry
Pharmaceuticals

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. The company is headquartered in Newport Beach, California and currently employs 167 full-time employees. The company went IPO on 2018-02-08. The Company’s first commercial product is Jeuveau, which is an approximately 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance. The company offers customers and consumers a compelling value proposition with Jeuveau. BOTOX (onabotulinumtoxinA) is also an approximately 900 kDa botulinum toxin type A complex approved in the United States.

EOLS Intrinsic Value
15.42 USD
Undervaluation 68%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett